Regions & Locations Guide 2012

Regions & Locations Guide 2012

Print edition as epaper.

Europe
04 Germany´s Chemical Parks
Investing in a Unique Range of Economic Benefits

06 Healthy German-Saudi Cooperation

08 Global Meets Local in Austria
Advancing Life Sciences at the Heart of Europe
Sonja Polan, LISA - Life Science Austria

10 Innovation as a Receipt for Success
With its Strategy of Specialization, Switzerland is
Holding its Own in International Competition
Dr. Beat Moser, Scienceindustries - Swiss Business Association
for the Chemical, Pharmaceutical and Biotech Industries

11 Chemical Industry in Italy

12 Poised for Recovery
Great Britain´s Traditional Chemical Clusters are turning
into Centers of Innovation
Sean Milmo, Essex

North America
14 Breaking New Ground
A Showcase of Ontario´s Excellence in Clinical Research
Dr. Terrie Romano, Ontario International Marketing Centre

15 Shale Gas Bonanza in the U.S.

Asia
16 India Catalyzed
The Indian Chemical Industry Provides Interesting Opportunities for Investors
Vir Lakshman, KPMG

17 Life Science Collaboration between Taiwan and Europe

18 Moving Ahead
Singapore is a Trusted Base for Manufacturing and R&D and Aims to be a Model of Sustainability
Kian Teik Beh, EDB Singapore 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.